Latest news with #Medtronicplc
Yahoo
24-05-2025
- Business
- Yahoo
Medtronic's (NYSE:MDT) Upcoming Dividend Will Be Larger Than Last Year's
The board of Medtronic plc (NYSE:MDT) has announced that it will be increasing its dividend by 1.4% on the 11th of July to $0.71, up from last year's comparable payment of $0.70. This will take the dividend yield to an attractive 3.5%, providing a nice boost to shareholder returns. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. We like to see robust dividend yields, but that doesn't matter if the payment isn't sustainable. Before this announcement, Medtronic was paying out 77% of earnings, but a comparatively small 69% of free cash flows. Since the dividend is just paying out cash to shareholders, we care more about the cash payout ratio from which we can see plenty is being left over for reinvestment in the business. Looking forward, earnings per share is forecast to rise by 25.2% over the next year. If the dividend continues along recent trends, we estimate the payout ratio will be 67%, which would make us comfortable with the sustainability of the dividend, despite the levels currently being quite high. See our latest analysis for Medtronic The company has been paying a dividend for a long time, and it has been quite stable which gives us confidence in the future dividend potential. The dividend has gone from an annual total of $1.22 in 2015 to the most recent total annual payment of $2.80. This implies that the company grew its distributions at a yearly rate of about 8.7% over that duration. Dividends have grown at a reasonable rate over this period, and without any major cuts in the payment over time, we think this is an attractive combination as it provides a nice boost to shareholder returns. Investors who have held shares in the company for the past few years will be happy with the dividend income they have received. Unfortunately, Medtronic's earnings per share has been essentially flat over the past five years, which means the dividend may not be increased each year. Earnings are not growing quickly at all, and the company is paying out most of its profit as dividends. This isn't the end of the world, but for investors looking for strong dividend growth they may want to look elsewhere. Overall, this is probably not a great income stock, even though the dividend is being raised at the moment. The company has been bring in plenty of cash to cover the dividend, but we don't necessarily think that makes it a great dividend stock. Overall, we don't think this company has the makings of a good income stock. Companies possessing a stable dividend policy will likely enjoy greater investor interest than those suffering from a more inconsistent approach. However, there are other things to consider for investors when analysing stock performance. As an example, we've identified 1 warning sign for Medtronic that you should be aware of before investing. If you are a dividend investor, you might also want to look at our curated list of high yield dividend stocks. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
24-05-2025
- Business
- Yahoo
Medtronic's (NYSE:MDT) Upcoming Dividend Will Be Larger Than Last Year's
The board of Medtronic plc (NYSE:MDT) has announced that it will be increasing its dividend by 1.4% on the 11th of July to $0.71, up from last year's comparable payment of $0.70. This will take the dividend yield to an attractive 3.5%, providing a nice boost to shareholder returns. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. We like to see robust dividend yields, but that doesn't matter if the payment isn't sustainable. Before this announcement, Medtronic was paying out 77% of earnings, but a comparatively small 69% of free cash flows. Since the dividend is just paying out cash to shareholders, we care more about the cash payout ratio from which we can see plenty is being left over for reinvestment in the business. Looking forward, earnings per share is forecast to rise by 25.2% over the next year. If the dividend continues along recent trends, we estimate the payout ratio will be 67%, which would make us comfortable with the sustainability of the dividend, despite the levels currently being quite high. See our latest analysis for Medtronic The company has been paying a dividend for a long time, and it has been quite stable which gives us confidence in the future dividend potential. The dividend has gone from an annual total of $1.22 in 2015 to the most recent total annual payment of $2.80. This implies that the company grew its distributions at a yearly rate of about 8.7% over that duration. Dividends have grown at a reasonable rate over this period, and without any major cuts in the payment over time, we think this is an attractive combination as it provides a nice boost to shareholder returns. Investors who have held shares in the company for the past few years will be happy with the dividend income they have received. Unfortunately, Medtronic's earnings per share has been essentially flat over the past five years, which means the dividend may not be increased each year. Earnings are not growing quickly at all, and the company is paying out most of its profit as dividends. This isn't the end of the world, but for investors looking for strong dividend growth they may want to look elsewhere. Overall, this is probably not a great income stock, even though the dividend is being raised at the moment. The company has been bring in plenty of cash to cover the dividend, but we don't necessarily think that makes it a great dividend stock. Overall, we don't think this company has the makings of a good income stock. Companies possessing a stable dividend policy will likely enjoy greater investor interest than those suffering from a more inconsistent approach. However, there are other things to consider for investors when analysing stock performance. As an example, we've identified 1 warning sign for Medtronic that you should be aware of before investing. If you are a dividend investor, you might also want to look at our curated list of high yield dividend stocks. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
24-05-2025
- Business
- Yahoo
Jim Cramer on Medtronic (MDT): 'I Like This Medical Device Powerhouse'
We recently published a list of . In this article, we are going to take a look at where Medtronic plc (NYSE:MDT) stands against other stocks on Jim Cramer's radar. On Friday's episode of Mad Money, Jim Cramer reflected on this week's market performance, with attention to upcoming earnings reports and broader market sentiment. 'Now we've been on a real rebound since post-Liberation Day meltdown back in the first week of April, with tech leading the way after really taking it on the chin.' READ ALSO: Jim Cramer Recently Commented On These 12 Stocks and Jim Cramer Put These 8 Stocks Under a Microscope Recently For this article, we compiled a list of 15 stocks that were discussed by Jim Cramer during the episodes of Mad Money aired on May 16. We listed the stocks in the order that Cramer mentioned them. We also provided hedge fund sentiment for each stock as of the fourth quarter of 2024, which was taken from Insider Monkey's database of over 1,000 hedge funds. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (). A surgeon in a modern operating room holding advanced medical devices with a sense of purpose and accuracy. Number of Hedge Fund Holders: 67 Noting Medtronic plc (NYSE:MDT) stock's inconsistency, Cramer advised investors to 'wait and see'. 'Also, Wednesday, we hear from Medtronic, and I like this medical device powerhouse, but the stock's been inconsistent even as the numbers tend to be pretty darn strong. That means it's hard to game. Another one, I gotta say, wait and see.' Medtronic (NYSE:MDT) is a well-known global company in medical technology that specializes in the development and sale of a broad range of medical devices and treatments. For the fiscal year 2025, the company expects organic revenue growth between 4.75% and 5% for the year. Additionally, Medtronic (NYSE:MDT) expects its diluted non-GAAP EPS to fall between $5.44 and $5.50, an expected increase of approximately 4.6% to 5.8% compared to the previous year. Overall, MDT ranks 11th on our list of stocks on Jim Cramer's radar. While we acknowledge the potential of MDT as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than MDT and that has 100x upside potential, check out our report about this cheapest AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
23-05-2025
- Business
- Yahoo
Medtronic chairman and CEO Geoff Martha to speak at Bernstein's Strategic Decisions Conference
GALWAY, Ireland, May 23, 2025 /CNW/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it will participate in Bernstein's 41st Strategic Decisions Conference on Thursday, May 29, 2025. Geoff Martha, Medtronic chairman and chief executive officer, will make a formal presentation beginning at 11:00 a.m. EDT (10:00 a.m. CDT). Immediately following the presentation, Martha will be joined by Thierry Piéton, Medtronic executive vice president and chief financial officer, to answer questions about the company. A live webcast of the presentation and Q&A session will be available on May 29, 2025, by clicking on the Events link at An archive of the presentation and Q&A session will be available on the same webpage later in the day. About MedtronicBold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic, visit and follow Medtronic on LinkedIn. Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results. ContactsErika WinkelsPublic Relations+1-763-526-8478 Ryan WeispfenningInvestor Relations+1-763-505-4626 View original content to download multimedia: SOURCE Medtronic plc View original content to download multimedia:
Cision Canada
23-05-2025
- Business
- Cision Canada
Medtronic chairman and CEO Geoff Martha to speak at Bernstein's Strategic Decisions Conference
GALWAY, Ireland, May 23, 2025 /CNW/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it will participate in Bernstein's 41st Strategic Decisions Conference on Thursday, May 29, 2025. Geoff Martha, Medtronic chairman and chief executive officer, will make a formal presentation beginning at 11:00 a.m. EDT (10:00 a.m. CDT). Immediately following the presentation, Martha will be joined by Thierry Piéton, Medtronic executive vice president and chief financial officer, to answer questions about the company. A live webcast of the presentation and Q&A session will be available on May 29, 2025, by clicking on the Events link at An archive of the presentation and Q&A session will be available on the same webpage later in the day. About Medtronic Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic, visit and follow Medtronic on LinkedIn. Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results. Contacts Erika Winkels Public Relations +1-763-526-8478 Ryan Weispfenning Investor Relations +1-763-505-4626 SOURCE Medtronic plc
